Indeed, RET inhibition was shown to increase the efficacy of antiestrogen drugs, and combined therapy of tamoxifen with vandetanib was proven as a potential treatment strategy for RET positive luminal breast cancers [45]. The gene discussed is RET; the disease is breast carcinoma.